- Report
- October 2024
- 198 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- December 2024
- 120 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2025
- 89 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- March 2025
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- May 2024
- 162 Pages
North America
From €3140EUR$3,450USD£2,692GBP
- Report
- June 2022
- 260 Pages
Global
From €3800EUR$4,175USD£3,257GBP
- Report
- January 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- July 2024
- 94 Pages
Global
From €3500EUR$4,120USD£3,106GBP
The Tropical Disease Test market is a subset of the Infectious Disease Testing market, focusing on the diagnosis of diseases that are endemic to tropical and subtropical regions. These diseases are caused by a variety of pathogens, including bacteria, viruses, fungi, and parasites. Tests used to diagnose tropical diseases include serological tests, such as ELISA and PCR, as well as antigen-based tests. These tests are used to detect the presence of specific pathogens in a patient's sample.
The Tropical Disease Test market is driven by the increasing prevalence of tropical diseases, as well as the need for accurate and timely diagnosis. The market is also driven by the development of new technologies, such as molecular diagnostics, which enable more accurate and rapid diagnosis.
Companies in the Tropical Disease Test market include Abbott Laboratories, Bio-Rad Laboratories, Cepheid, DiaSorin, and Hologic. Show Less Read more